Research ExplorerScientific StaffWalter Fiedler Publications

Prof.Dr. ID: 50717

Walter Fiedler

graph of relations
Affiliations
101 - 150 out of 195Page size: 50

Publications

  1. 2018

  2. Highly specific targeting of human acute myeloid leukaemia cells using pharmacologically active nanoconjugates

    Yasinska, I. M., Ceccone, G., Ojea-Jimenez, I., Ponti, J., Hussain, R., Siligardi, G., Berger, S. M., Fasler-Kan, E., Bardelli, M., Varani, L., Fiedler, W., Wellbrock, J., Raap, U., Gibbs, B. F., Calzolai, L. & Sumbayev, V. V., 29.03.2018, In: NANOSCALE. 10, 13, p. 5827-5833 7 p.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  3. Acute hepatitis as a prequel to very severe aplastic anemia

    Weiler-Normann, C., Hartl, J., Weidemann, S., von Pein, U-M., Fiedler, W., Schramm, C., Brinkert, F., Kröger, N. & Christopeit, M., 01.2018, In: Z GASTROENTEROL. 56, 1, p. 51-54 4 p.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  4. DNMT3A mutant transcript levels persist in remission and do not predict outcome in patients with acute myeloid leukemia

    Gaidzik, V. I., Weber, D., Paschka, P., Kaumanns, A., Krieger, S., Corbacioglu, A., Krönke, J., Kapp-Schwoerer, S., Krämer, D., Horst, H-A., Schmidt-Wolf, I. G. H., Held, G., Kündgen, A., Ringhoffer, M., Götze, K., Kindler, T., Fiedler, W., Wattad, M., Schlenk, R. F., Bullinger, L., Teleanu, V., Schlegelberger, B., Thol, F., Heuser, M., Ganser, A., Döhner, H. & Döhner, K., 01.2018, In: LEUKEMIA. 32, 1, p. 30-37 8 p.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  5. A multicenter phase 1 study of solitomab (MT110, AMG 110), a bispecific EpCAM/CD3 T-cell engager (BiTE®) antibody construct, in patients with refractory solid tumors

    Kebenko, M., Goebeler, M-E., Wolf, M., Hasenburg, A., Seggewiss-Bernhardt, R., Ritter, B., Rautenberg, B., Atanackovic, D., Kratzer, A., Rottman, J. B., Friedrich, M., Vieser, E., Elm, S., Patzak, I., Wessiepe, D., Stienen, S. & Fiedler, W., 2018, In: ONCOIMMUNOLOGY. 7, 8, p. e1450710

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  6. High mobility group box 1 (HMGB1) acts as an "alarmin" to promote acute myeloid leukaemia progression

    Yasinska, I. M., Gonçalves Silva, I., Sakhnevych, S. S., Ruegg, L., Hussain, R., Siligardi, G., Fiedler, W., Wellbrock, J., Bardelli, M., Varani, L., Raap, U., Berger, S., Gibbs, B. F., Fasler-Kan, E. & Sumbayev, V. V., 2018, In: ONCOIMMUNOLOGY. 7, 6, p. e1438109

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  7. Phase I study of tomuzotuximab, a glycoengineered therapeutic antibody against the epidermal growth factor receptor, in patients with advanced carcinomas

    Fiedler, W., Cresta, S., Schulze-Bergkamen, H., De Dosso, S., Weidmann, J., Tessari, A., Baumeister, H., Danielczyk, A., Dietrich, B., Goletz, S., Zurlo, A., Salzberg, M., Sessa, C. & Gianni, L., 2018, In: ESMO OPEN. 3, 2, p. e000303

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  8. Phase I study of TrasGEX, a glyco-optimised anti-HER2 monoclonal antibody, in patients with HER2-positive solid tumours

    Fiedler, W., Stoeger, H., Perotti, A., Gastl, G., Weidmann, J., Dietrich, B., Baumeister, H., Danielczyk, A., Goletz, S., Salzberg, M. & De Dosso, S., 2018, In: ESMO OPEN. 3, 4, p. e000381

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  9. 2017

  10. Epidemiological, genetic, and clinical characterization by age of newly diagnosed acute myeloid leukemia based on an academic population-based registry study (AMLSG BiO)

    Nagel, G., Weber, D., Fromm, E., Erhardt, S., Lübbert, M., Fiedler, W., Kindler, T., Krauter, J., Brossart, P., Kündgen, A., Salih, H. R., Westermann, J., Wulf, G., Hertenstein, B., Wattad, M., Götze, K., Kraemer, D., Heinicke, T., Girschikofsky, M., Derigs, H. G., Horst, H. A., Rudolph, C., Heuser, M., Göhring, G., Teleanu, V., Bullinger, L., Thol, F., Gaidzik, V. I., Paschka, P., Döhner, K., Ganser, A., Döhner, H., Schlenk, R. F. & German-Austrian AML Study Group (AMLSG), 12.2017, In: ANN HEMATOL. 96, 12, p. 1993-2003 11 p.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  11. SHIP1, but not an AML-derived SHIP1 mutant, suppresses myeloid leukemia growth in a xenotransplantation mouse model

    Täger, M., Horn, S., Latuske, E., Ehm, P., Schaks, M., Nalaskowski, M., Fehse, B., Fiedler, W., Stocking, C., Wellbrock, J. & Jücker, M., 11.2017, In: GENE THER. 24, 11, p. 749-753 5 p.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  12. The Tim-3-galectin-9 Secretory Pathway is Involved in the Immune Escape of Human Acute Myeloid Leukemia Cells

    Gonçalves Silva, I., Yasinska, I. M., Sakhnevych, S. S., Fiedler, W., Wellbrock, J., Bardelli, M., Varani, L., Hussain, R., Siligardi, G., Ceccone, G., Berger, S. M., Ushkaryov, Y. A., Gibbs, B. F., Fasler-Kan, E. & Sumbayev, V. V., 08.2017, In: EBIOMEDICINE. 22, p. 44-57 14 p.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  13. Acute myeloid leukemia derived from lympho-myeloid clonal hematopoiesis

    Thol, F., Klesse, S., Köhler, L., Gabdoulline, R., Kloos, A., Liebich, A., Wichmann, M., Chaturvedi, A., Fabisch, J., Gaidzik, V. I., Paschka, P., Bullinger, L., Bug, G., Serve, H., Göhring, G., Schlegelberger, B., Lübbert, M., Kirchner, H., Wattad, M., Kraemer, D., Hertenstein, B., Heil, G., Fiedler, W., Krauter, J., Schlenk, R. F., Döhner, K., Döhner, H., Ganser, A. & Heuser, M., 06.2017, In: LEUKEMIA. 31, 6, p. 1286-1295

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  14. The hypomorphic TERT A1062T variant is associated with increased treatment-related toxicity in acute myeloid leukemia

    Both, A., Krauter, J., Damm, F., Thol, F., Göhring, G., Heuser, M., Ottmann, O., Lübbert, M., Wattad, M., Kanz, L., Schlimok, G., Raghavachar, A., Fiedler, W., Kirchner, H., Brugger, W., Schlegelberger, B., Heil, G., Ganser, A. & Wagner, K., 06.2017, In: ANN HEMATOL. 96, 6, p. 895-904

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  15. Zielgerichtete Therapie und Immuntherapie bei der AML

    Janning, M. & Fiedler, W., 06.2017, In: J Onkol - Z Onkol Fortb. 5, 05, p. 184-191

    Research output: SCORING: Contribution to journal › SCORING: Review article › Research

  16. Condensed versus standard schedule of high-dose cytarabine consolidation therapy with pegfilgrastim growth factor support in acute myeloid leukemia

    Jaramillo, S., Benner, A., Krauter, J., Martin, H., Kindler, T., Bentz, M., Salih, H. R., Held, G., Köhne, C-H., Götze, K., Lübbert, M., Kündgen, A., Brossart, P., Wattad, M., Salwender, H., Hertenstein, B., Nachbaur, D., Wulf, G., Horst, H-A., Kirchen, H., Fiedler, W., Raghavachar, A., Russ, G., Kremers, S., Koller, E., Runde, V., Heil, G., Weber, D., Göhring, G., Döhner, K., Ganser, A., Döhner, H. & Schlenk, R. F., 26.05.2017, In: BLOOD CANCER J. 7, 5, p. e564

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  17. Impact of pretreatment characteristics and salvage strategy on outcome in patients with relapsed acute myeloid leukemia

    Schlenk, R. F., Frech, P., Weber, D., Brossart, P., Horst, H-A., Kraemer, D., Held, G., Ringhoffer, M., Burchardt, A., Kobbe, G., Götze, K., Nachbaur, D., Fischer, T., Lübbert, M., Salih, H. R., Salwender, H., Wulf, G., Koller, E., Wattad, M., Fiedler, W., Kremers, S., Kirchen, H., Hertenstein, B., Paschka, P., Gaidzik, V. I., Teleanu, V., Heuser, M., Thol, F., Döhner, K., Krauter, J., Ganser, A. & Döhner, H., 05.2017, In: LEUKEMIA. 31, 5, p. 1217-1220

    Research output: SCORING: Contribution to journal › Other (editorial matter etc.) › Research

  18. Combined inhibition of GLI and FLT3 signaling leads to effective anti-leukemic effects in human acute myeloid leukemia

    Latuske, E-M., Stamm, H., Klokow, M., Vohwinkel, G., Muschhammer, J., Bokemeyer, C., Jücker, M., Kebenko, M., Fiedler, W. & Wellbrock, J., 25.04.2017, In: ONCOTARGET. 8, 17, p. 29187-29201

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  19. Incidence and prognostic impact of ASXL2 mutations in adult acute myeloid leukemia patients with t(8;21)(q22;q22): A study of the German-Austrian AML study group (AMLSG)

    Jahn, N., Agrawal, M., Bullinger, L., Weber, D., Corbacioglu, A., Gaidzik, V. I., Schmalbrock, L., Thol, F., Heuser, M., Krauter, J., Göhring, G., Kündgen, A., Fiedler, W., Wattad, M., Held, G., Köhne, C-H., Horst, H-A., Lübbert, M., Ganser, A., Schlenk, R. F., Döhner, H., Döhner, K. & Paschka, P., 04.2017, In: LEUKEMIA. 31, 4, p. 1012-1015

    Research output: SCORING: Contribution to journal › Other (editorial matter etc.) › Research

  20. Relevance of the Hedgehog pathway in T-cell acute lymphoblastic leukemia

    Wellbrock, J. & Fiedler, W., 02.03.2017, In: TRANSL CANCER RES. 6, Suppl 2, p. 286-291

    Research output: SCORING: Contribution to journal › Other (editorial matter etc.) › Research

  21. Improved Outcomes With Retinoic Acid and Arsenic Trioxide Compared With Retinoic Acid and Chemotherapy in Non-High-Risk Acute Promyelocytic Leukemia: A study of the AML study group (AMLSG)

    Platzbecker, U., Avvisati, G., Cicconi, L., Thiede, C., Paoloni, F., Vignetti, M., Ferrara, F., Divona, M., Albano, F., Efficace, F., Fazi, P., Sborgia, M., Di Bona, E., Breccia, M., Borlenghi, E., Cairoli, R., Rambaldi, A., Melillo, L., La Nasa, G., Fiedler, W., Brossart, P., Hertenstein, B., Salih, H. R., Wattad, M., Lübbert, M., Brandts, C. H., Hänel, M., Röllig, C., Schmitz, N., Link, H., Frairia, C., Pogliani, E. M., Fozza, C., D'Arco, A. M., Di Renzo, N., Cortelezzi, A., Fabbiano, F., Döhner, K., Ganser, A., Döhner, H., Amadori, S., Mandelli, F., Ehninger, G., Schlenk, R. F. & Lo-Coco, F., 20.02.2017, In: J CLIN ONCOL. 35, 6, p. 605-612

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  22. 2016

  23. All-trans retinoic acid as adjunct to intensive treatment in younger adult patients with acute myeloid leukemia: results of the randomized AMLSG 07-04 study

    Schlenk, R. F., Lübbert, M., Benner, A., Lamparter, A., Krauter, J., Herr, W., Martin, H., Salih, H. R., Kündgen, A., Horst, H-A., Brossart, P., Götze, K., Nachbaur, D., Wattad, M., Köhne, C-H., Fiedler, W., Bentz, M., Wulf, G., Held, G., Hertenstein, B., Salwender, H., Gaidzik, V. I., Schlegelberger, B., Weber, D., Döhner, K., Ganser, A., Döhner, H. & German-Austrian Acute Myeloid Leukemia Study Group, 01.12.2016, In: ANN HEMATOL. 95, 12, p. 1931-1942

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  24. Clinical impact of GATA2 mutations in acute myeloid leukemia patients harboring CEBPA mutations: A study of the AML study group (AMLSG)

    Theis, F., Corbacioglu, A., Gaidzik, V. I., Paschka, P., Weber, D., Bullinger, L., Heuser, M., Ganser, A., Thol, F., Schlegelberger, B., Göhring, G., Köhne, C-H., Germing, U., Brossart, P., Horst, H-A., Haase, D., Götze, K., Ringhoffer, M., Fiedler, W., Nachbaur, D., Kindler, T., Held, G., Lübbert, M., Wattad, M., Salih, H. R., Krauter, J., Schlenk, R. F. & Döhner, K., 11.2016, In: LEUKEMIA. 30, 11, p. 2248-2250

    Research output: SCORING: Contribution to journal › Other (editorial matter etc.) › Research

  25. Akute Myeloische Leukämie.

    Fiedler, W. & Janning, M., 10.2016, In: Aktuelle Gesundheitsnachrichten .

    Research output: SCORING: Contribution to journal › Other (editorial matter etc.) › Research

  26. Deoxycytidine kinase is downregulated under hypoxic conditions and confers resistance against cytarabine in acute myeloid leukaemia

    Degwert, N., Latuske, E., Vohwinkel, G., Stamm, H., Klokow, M., Bokemeyer, C., Fiedler, W. & Wellbrock, J., 09.2016, In: EUR J HAEMATOL. 97, 3, p. 239-44

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  27. Salvage therapy with high-dose cytarabine and mitoxantrone in combination with all-trans retinoic acid and gemtuzumab ozogamicin in acute myeloid leukemia refractory to first induction therapy

    Hütter-Krönke, M-L., Benner, A., Döhner, K., Krauter, J., Weber, D., Moessner, M., Köhne, C-H., Horst, H. A., Schmidt-Wolf, I. G. H., Rummel, M., Götze, K., Koller, E., Petzer, A. L., Salwender, H., Fiedler, W., Kirchen, H., Haase, D., Kremers, S., Theobald, M., Matzdorff, A. C., Ganser, A., Döhner, H. & Schlenk, R. F., 07.2016, In: HAEMATOLOGICA. 101, 7, p. 839-45

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  28. A phase I study of PankoMab-GEX, a humanised glyco-optimised monoclonal antibody to a novel tumour-specific MUC1 glycopeptide epitope in patients with advanced carcinomas

    Fiedler, W., DeDosso, S., Cresta, S., Weidmann, J., Tessari, A., Salzberg, M., Dietrich, B., Baumeister, H., Goletz, S., Gianni, L. & Sessa, C., 07.06.2016, In: EUR J CANCER. 63, p. 55-63 9 p.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  29. Phase I clinical study of RG7356, an anti-CD44 humanized antibody, in patients with acute myeloid leukemia

    Vey, N., Delaunay, J., Martinelli, G., Fiedler, W., Raffoux, E., Prebet, T., Gomez-Roca, C., Papayannidis, C., Kebenko, M., Paschka, P., Christen, R., Guarin, E., Bröske, A-M., Baehner, M., Brewster, M., Walz, A-C., Michielin, F., Runza, V., Meresse, V. & Recher, C., 31.05.2016, In: ONCOTARGET. 7, 22, p. 32532-42

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  30. Sunitinib treatment reduces tumor growth and limits changes in microvascular properties after minor surgical intervention in an in vivo model of secondary breast cancer growth in bone

    Schroeder, M., Viezens, L., Wellbrock, J., Fiedler, W., Ruether, W., Algenstaedt, P., Hansen-Algenstaedt, N. & Schäfer, C., 04.2016, In: J SURG ONCOL. 113, 5, p. 515-21

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  31. Hodgkin's lymphoma as a rare variant of Richter's transformation in chronic lymphocytic leukemia: A case report and review of the literature

    Janjetovic, S., Bernd, H-W., Bokemeyer, C. & Fiedler, W., 03.2016, In: MOL CLIN ONCOL. 4, 3, p. 390-392 3 p.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  32. 2015

  33. The Rare Occurrence of the Translocation t(8;14) in Chronic Lymphatic Leukemia: Case Report and Review of the Literature

    Coym, A., Janjetovic, S., Bokemeyer, C. & Fiedler, W., 03.06.2015, In: Ann Hematol Oncol. 2, 5, p. 1039

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  34. Intrinsic BMP Antagonist Gremlin-1 as a Novel Circulating Marker in Pulmonary Arterial Hypertension

    Wellbrock, J., Harbaum, L., Stamm, H., Hennigs, J. K., Schulz, B., Klose, H., Bokemeyer, C., Fiedler, W. & Lüneburg, N., 30.04.2015, In: LUNG.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  35. A phase I/II study of sunitinib and intensive chemotherapy in patients over 60 years of age with acute myeloid leukaemia and activating FLT3 mutations

    Fiedler, W., Kayser, S., Kebenko, M., Janning, M., Krauter, J., Schittenhelm, M., Götze, K., Weber, D., Göhring, G., Teleanu, V., Thol, F., Heuser, M., Döhner, K., Ganser, A., Döhner, H. & Schlenk, R. F., 29.03.2015, In: BRIT J HAEMATOL.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  36. Expression of Hedgehog Pathway Mediator GLI Represents a Negative Prognostic Marker in Human Acute Myeloid Leukemia and Its Inhibition Exerts Antileukemic Effects

    Wellbrock, J., Latuske, E., Köhler, J., Wagner, K., Stamm, H., Vettorazzi, E., Vohwinkel, G., Klokow, M., Uibeleisen, R., Ehm, P., Riecken, K., Loges, S., Thol, F., Schubert, C., Amling, M., Jücker, M., Bokemeyer, C., Heuser, M., Krauter, J. & Fiedler, W., 05.03.2015, In: CLIN CANCER RES.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  37. Role of Growth arrest-specific gene 6-Mer axis in multiple myeloma

    Waizenegger, J. S., Ben-Batalla, I., Weinhold, N., Meissner, T., Wroblewski, M., Janning, M., Riecken, K., Binder, M., Atanackovic, D., Taipaleenmaeki, H., Schewe, D., Sawall, S., Gensch, V., Cubas-Cordova, M., Seckinger, A., Fiedler, W., Hesse, E., Kröger, N., Fehse, B., Hose, D., Klein, B., Raab, M. S., Pantel, K., Bokemeyer, C. & Loges, S., 01.03.2015, In: LEUKEMIA. 29, 3, p. 696-704 9 p.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  38. ErbB2 signaling activates the Hedgehog pathway via PI3K-Akt in human esophageal adenocarcinoma: Identification of novel targets for concerted therapy concepts

    Kebenko, M., Drenckhan, A., Gros, S. J., Jücker, M., Grabinski, N., Ewald, F., Grottke, A., Schultze, A., Izbicki, J. R., Bokemeyer, C., Wellbrock, J. & Fiedler, W., 01.02.2015, In: CELL SIGNAL. 27, 2, p. 373-81 9 p.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  39. Thrombin generation in a patient with an acquired high-titre factor V inhibitor

    Schmidt, D. E., Steinhagen, F., Schnabel, C., Spath, B., Holstein, K., Fiedler, W., Bokemeyer, C., Renné, T. & Langer, F., 2015, In: BLOOD COAGUL FIBRIN. 26, 1, p. 81-87

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  40. 2014

  41. Clinical and functional implications of microRNA mutations in a cohort of 935 patients with myelodysplastic syndromes and acute myeloid leukemia

    Thol, F., Scherr, M., Kirchner, A., Shahswar, R., Battmer, K., Kade, S., Chaturvedi, A., Koenecke, C., Stadler, M., Platzbecker, U., Thiede, C., Schroeder, T., Kobbe, G., Bug, G., Ottmann, O., Hofmann, W-K., Kröger, N., Fiedler, W., Schlenk, R., Döhner, K., Döhner, H., Krauter, J., Eder, M., Ganser, A. & Heuser, M., 31.12.2014, In: HAEMATOLOGICA.

    Research output: SCORING: Contribution to journal › Other (editorial matter etc.) › Research

  42. Randomized, phase 2 trial of low-dose cytarabine with or without volasertib in AML patients not suitable for induction therapy

    Döhner, H., Lübbert, M., Fiedler, W., Fouillard, L., Haaland, A., Brandwein, J. M., Lepretre, S., Reman, O., Turlure, P., Ottmann, O. G., Müller-Tidow, C., Krämer, A., Raffoux, E., Döhner, K., Schlenk, R. F., Voss, F., Taube, T., Fritsch, H. & Maertens, J., 28.08.2014, In: BLOOD. 124, 9, p. 1426-33 8 p.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  43. Volasertib for the treatment of acute myeloid leukemia: a review of preclinical and clinical development

    Janning, M. & Fiedler, W., 01.05.2014, In: FUTURE ONCOL. 10, 7, p. 1157-65 9 p.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  44. Akute myeloische Leukämie –bestmögliche Behandlung.

    Fiedler, W., Janning, M., Kebenko, M., Weidmann, J., Janjetovic, S. & Bokemeyer, C., 10.02.2014, In: Hamb Ärztebl. 68, p. 11-17 6 p.

    Research output: SCORING: Contribution to journal › Newspaper articles › Transfer

  45. New antiangiogenic strategies beyond inhibition of vascular endothelial growth factor with special focus on axon guidance molecules

    Pircher, A., Wellbrock, J., Fiedler, W., Heidegger, I., Gunsilius, E. & Hilbe, W., 01.01.2014, In: NEURO-ONCOLOGY. 86, 1, p. 46-52 7 p.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  46. Overexpression of Gremlin-1 in Patients with Loeys-Dietz Syndrome: Implications on Pathophysiology and Early Disease Detection

    Wellbrock, J., Sheikhzadeh, S., Oliveira Ferrer, L., Stamm, H., Hillebrand, M., Keyser, B., Klokow, M., Vohwinkel, G., Bonk, V., Otto, B., Streichert, T., Balabanov, S., Hagel, C., Rybczynski, M., Bentzien, F., Bokemeyer, C., Kodolitsch, Y. & Fiedler, W., 01.01.2014, In: PLOS ONE. 9, 8, p. e104742

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  47. 2013

  48. Axl, a prognostic and therapeutic target in acute myeloid leukemia mediates paracrine crosstalk of leukemia cells with bone marrow stroma

    Ben Batalla, I., Schultze, A., Wroblewski, M., Erdmann, R., Heuser, M., Waizenegger, J. S., Riecken, K., Binder, M., Schewe, D., Sawall, S., Witzke, V., Cubas Cordova, M., Janning, M., Wellbrock, J., Fehse, B., Hagel, C., Krauter, J., Ganser, A., Lorens, J. B., Fiedler, W., Carmeliet, P., Pantel, K., Bokemeyer, C. & Loges, S., 03.10.2013, In: BLOOD. 122, 14, p. 2443-52 10 p.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  49. Retinoic acid and arsenic trioxide for acute promyelocytic leukemia

    Lo-Coco, F., Avvisati, G., Vignetti, M., Thiede, C., Orlando, S. M., Iacobelli, S., Ferrara, F., Fazi, P., Cicconi, L., Di Bona, E., Specchia, G., Sica, S., Divona, M., Levis, A., Fiedler, W., Cerqui, E., Breccia, M., Fioritoni, G., Salih, H. R., Cazzola, M., Melillo, L., Carella, A. M., Brandts, C. H., Morra, E., von Lilienfeld-Toal, M., Hertenstein, B., Wattad, M., Lübbert, M., Hänel, M., Schmitz, N., Link, H., Kropp, M. G., Rambaldi, A., La Nasa, G., Luppi, M., Ciceri, F., Finizio, O., Venditti, A., Fabbiano, F., Döhner, K., Sauer, M., Ganser, A., Amadori, S., Mandelli, F., Döhner, H., Ehninger, G., Schlenk, R. F., Platzbecker, U. & Gruppo Italiano Malattie Ematologiche dell'Adulto, 11.07.2013, In: NEW ENGL J MED. 369, 2, p. 111-21 11 p.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  50. Combination therapy targeting integrins reduces glioblastoma tumor growth through antiangiogenic and direct antitumor activity and leads to activation of the pro-proliferative prolactin pathway

    Oliveira Ferrer, L., Wellbrock, J., Bartsch, U., Penas, E. M. M., Hauschild, J., Klokow, M., Bokemeyer, C., Fiedler, W. & Schuch, G., 01.01.2013, In: MOL CANCER. 12, 1, p. 144

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  51. Late recurrence of a pineal germinoma 14 years after radiation and chemotherapy: a case report and review of the literature

    Janjetovic, S., Bokemeyer, C., Fiedler, W., Frenzel, T., Calaminus, G. & Honecker, F., 01.01.2013, In: ONKOLOGIE. 36, 6, p. 371-3 3 p.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  52. Acute megakaryoblastic leukemia in a patient with xeroderma pigmentosum: discussion of pathophysiological, prognostic, and toxicological aspects.

    Janjetovic, S., Bacher, U., Haalck, T., Janning, M., Bokemeyer, C. & Fiedler, W., 2013, In: ACTA HAEMATOL-BASEL. 129, 2, p. 121-125 5 p., 2.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  53. Chylothorax in a patient with Hodgkin's lymphoma: a case report and review of the literature

    Janjetovic, S., Janning, M., Daukeva, L., Bokemeyer, C. & Fiedler, W., 2013, In: TUMORI J. 99, 3, p. e96-9

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  54. Prognostic significance of expression levels of stem cell regulators MSI2 and NUMB in acute myeloid leukemia.

    Thol, F., Winschel, C., Sonntag, A-K., Damm, F., Wagner, K., Chaturvedi, A., Göhring, G., Schlegelberger, B., Lübbert, M., Fiedler, W., Kirchner, H., Krauter, J., Ganser, A. & Heuser, M., 2013, In: ANN HEMATOL. 92, 3, p. 315-323 9 p., 3.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  55. 2012

  56. VEGFR-1 expression levels predict occurrence of disseminated tumor cells in the bone marrow of patients with esophageal carcinoma

    Schultze, A., Ben-Batalla, I., Riethdorf, S., Bubenheim, M., Yekebas, E. F., Erbersdobler, A., Reichelt, U., Harms-Effenberger, K., Schmidt, T., Izbicki, J. R., Bokemeyer, C., Pantel, K., Fiedler, W. & Loges, S., 12.2012, In: CLIN EXP METASTAS. 29, 8, p. 879-887 9 p., 8.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  57. CD146: a new partner for VEGFR2.

    Wellbrock, J. & Fiedler, W., 2012, In: BLOOD. 120, 11, p. 2164-2165 11.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

Previous 1 2 3 4 Next